SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Concepción García, Cristina Palomo-Garo, Yolanda Gómez-Gálvez, Javier Fernández-Ruiz, Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia, British Journal of Pharmacology, 2016, 173, 4
  2. 2
    Glenn M. Dallérac, Damian M. Cummings, Mark C. Hirst, Austen J. Milnerwood, Kerry P. S. J. Murphy, Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington’s Disease, NeuroMolecular Medicine, 2016,

    CrossRef

  3. 3
    Liliya Iskhakova, Yoland Smith, mGluR4-containing corticostriatal terminals: synaptic interactions with direct and indirect pathway neurons in mice, Brain Structure and Function, 2016,

    CrossRef

  4. 4
    Kalynda K. Gonzales, Yoland Smith, Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions, Annals of the New York Academy of Sciences, 2015, 1349, 1
  5. 5
    Robert B. Laprairie, Amina M. Bagher, Sophie V. Precious, Eileen M. Denovan-Wright, Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets, Pharmacology Research & Perspectives, 2015, 3, 1
  6. 6
    Saki Shimizu, Yuto Mizuguchi, Akira Sobue, Mai Fujiwara, Tomoki Morimoto, Yukihiro Ohno, Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice, Journal of Pharmacological Sciences, 2015, 127, 4, 439

    CrossRef

  7. 7
    Tomás R. Guilarte, Kalynda K. Gonzales, Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson’s Disease: Environmental and Genetic Evidence, Toxicological Sciences, 2015, 146, 2, 204

    CrossRef

  8. 8
    C. F. Freyschlag, J. Kerschbaumer, C. Thomé, Maximizing the Extent of Resection in Gliomas: Intraoperative Awake Mapping Versus Intraoperative Imaging, Neuro-Oncology Practice, 2015, 5, 1, 38

    CrossRef

  9. 9
    Panchanan Maiti, Jayeeta Manna, G. Ilavazhagan, Julien Rossignol, Gary L. Dunbar, Molecular regulation of dendritic spine dynamics and their potential impact on synaptic plasticity and neurological diseases, Neuroscience & Biobehavioral Reviews, 2015, 59, 208

    CrossRef

  10. 10
    Rosa M. Villalba, Abraham Mathai, Yoland Smith, Morphological changes of glutamatergic synapses in animal models of Parkinson’s disease, Frontiers in Neuroanatomy, 2015, 9,

    CrossRef

  11. 11
    Lara Eid, Martin Parent, Morphological evidence for dopamine interactions with pallidal neurons in primates, Frontiers in Neuroanatomy, 2015, 9,

    CrossRef

  12. 12
    Federico Nemmi, Umberto Sabatini, Olivier Rascol, Patrice Péran, Parkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis, Neurobiology of Aging, 2015, 36, 1, 424

    CrossRef

  13. 13
    K.L. Eskow Jaunarajs, P. Bonsi, M.F. Chesselet, D.G. Standaert, A. Pisani, Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia, Progress in Neurobiology, 2015, 127-128, 91

    CrossRef

  14. 14
    L. Yetnikoff, H.N. Lavezzi, R.A. Reichard, D.S. Zahm, An update on the connections of the ventral mesencephalic dopaminergic complex, Neuroscience, 2014, 282, 23

    CrossRef

  15. 15
    Minjeong Kim, Sangwook Seo, Kyunghwa Sung, Kisok Kim, Arsenic Exposure in Drinking Water Alters the Dopamine System in the Brains of C57BL/6 Mice, Biological Trace Element Research, 2014, 162, 1-3, 175

    CrossRef

  16. 16
    Abdelhamid Benazzouz, Omar Mamad, Pamphyle Abedi, Rabia Bouali-Benazzouz, Jonathan Chetrit, Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson’s disease, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  17. 17
    Pablo Garrido-Gil, Rita Valenzuela, Begoña Villar-Cheda, Jose L. Lanciego, Jose L. Labandeira-Garcia, Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin–angiotensin system in the nigra, Brain Structure and Function, 2013, 218, 2, 373

    CrossRef

  18. 18
    P.M. Abedi, C. Delaville, P. De Deurwaerdère, W. Benjelloun, A. Benazzouz, Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat, Neuroscience, 2013, 236, 289

    CrossRef

  19. 19
    O. D. Howes, M. Williams, K. Ibrahim, G. Leung, A. Egerton, P. K. McGuire, F. Turkheimer, Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study, Brain, 2013, 136, 11, 3242

    CrossRef

  20. 20
    Limin Shi, Xiling Bian, Zhiqiang Qu, Zegang Ma, Yu Zhou, KeWei Wang, Hong Jiang, Junxia Xie, Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels, Nature Communications, 2013, 4, 1435

    CrossRef

  21. 21
    Arthur Leblois, Social modulation of learned behavior by dopamine in the basal ganglia: Insights from songbirds, Journal of Physiology-Paris, 2013, 107, 3, 219

    CrossRef

  22. 22
    Lawrence C. Blume, Caroline E. Bass, Steven R. Childers, George D. Dalton, David C. S. Roberts, Jasmine M. Richardson, Ruoyu Xiao, Dana E. Selley, Allyn C. Howlett, Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and delta opioid systems, Journal of Neurochemistry, 2013, 124, 6
  23. 23
    Nicholas W. Sterling, Guangwei Du, Mechelle M. Lewis, Christopher Dimaio, Lan Kong, Paul J. Eslinger, Martin Styner, Xuemei Huang, Striatal shape in Parkinson's disease, Neurobiology of Aging, 2013, 34, 11, 2510

    CrossRef

  24. 24
    C. Marin, M. Bonastre, G. Mengod, R. Cortés, M.C. Rodríguez-Oroz, J.A. Obeso, Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease, Experimental Neurology, 2013, 250, 304

    CrossRef

  25. 25
    Luca Ferraro, Sarah Beggiato, Maria Cristina Tomasini, Kjell Fuxe, Tiziana Antonelli, Sergio Tanganelli, A2A/D2 receptor heteromerization in a model of Parkinson's disease. Focus on striatal aminoacidergic signaling, Brain Research, 2012, 1476, 96

    CrossRef

  26. 26
    Andrea de Bartolomeis, Carmine Tomasetti, Calcium-Dependent Networks in Dopamine–Glutamate Interaction: The Role of Postsynaptic Scaffolding Proteins, Molecular Neurobiology, 2012, 46, 2, 275

    CrossRef

  27. 27
    Megan L. Fitzgerald, Eli Shobin, Virginia M. Pickel, Cannabinoid modulation of the dopaminergic circuitry: Implications for limbic and striatal output, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2012, 38, 1, 21

    CrossRef

  28. 28
    Sarah A. Eisenstein, Jon M. Koller, Marilyn Piccirillo, Ana Kim, Jo Ann V. Antenor-Dorsey, Tom O. Videen, Abraham Z. Snyder, Morvarid Karimi, Stephen M. Moerlein, Kevin J. Black, Joel S. Perlmutter, Tamara Hershey, Characterization of extrastriatal D2 in vivo specific binding of [18F](N-methyl)benperidol using PET, Synapse, 2012, 66, 9
  29. 29
    Michael J. Zigmond, Judy L. Cameron, Barry J. Hoffer, Richard J. Smeyne, Neurorestoration by physical exercise: Moving forward, Parkinsonism & Related Disorders, 2012, 18, S147

    CrossRef

  30. 30
    Daniel P. Czech, Joohyung Lee, Helena Sim, Clare L. Parish, Eric Vilain, Vincent R. Harley, The human testis-determining factor SRY localizes in midbrain dopamine neurons and regulates multiple components of catecholamine synthesis and metabolism, Journal of Neurochemistry, 2012, 122, 2
  31. 31
    Peter Dayan, Neuroscience of Preference and Choice, 2012,

    CrossRef

  32. 32
    Thomas Wichmann, Mahlon R. DeLong, Basic Neurochemistry, 2012,

    CrossRef

  33. 33
    G. Martella, G. Madeo, T. Schirinzi, A. Tassone, G. Sciamanna, F. Spadoni, A. Stefani, J. Shen, A. Pisani, P. Bonsi, Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease, Neuroscience, 2011, 177, 240

    CrossRef

  34. 34
    Rosa M. Villalba, Yoland Smith, Differential structural plasticity of corticostriatal and thalamostriatal axo-spinous synapses in MPTP-treated parkinsonian monkeys, Journal of Comparative Neurology, 2011, 519, 5
  35. 35
    A. Rieckmann, S. Karlsson, P. Karlsson, Y. Brehmer, H. Fischer, L. Farde, L. Nyberg, L. Backman, Dopamine D1 Receptor Associations within and between Dopaminergic Pathways in Younger and Elderly Adults: Links to Cognitive Performance, Cerebral Cortex, 2011, 21, 9, 2023

    CrossRef

  36. 36
    R Mark Richardson, Adrian P Kells, Kathryn H Rosenbluth, Ernesto Aguilar Salegio, Massimo S Fiandaca, Paul S Larson, Philip A Starr, Alastair J Martin, Russell R Lonser, Howard J Federoff, John R Forsayeth, Krystof S Bankiewicz, Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease, Molecular Therapy, 2011, 19, 6, 1048

    CrossRef

  37. 37
    Zsofia Nemoda, Anna Szekely, Maria Sasvari-Szekely, Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood, Neuroscience & Biobehavioral Reviews, 2011, 35, 8, 1665

    CrossRef

  38. 38
    Kurt A. Jellinger, Youmans Neurological Surgery, 2011,

    CrossRef

  39. 39
    Yoland Smith, Youmans Neurological Surgery, 2011,

    CrossRef

  40. 40
    Roberta Cavalcanti-Kwiatkoski, Rita Raisman-Vozari, Laure Ginestet, Elaine Del Bel, Altered expression of neuronal nitric oxide synthase in weaver mutant mice, Brain Research, 2010, 1326, 40

    CrossRef

  41. 41
    Emma Perez-Costas, Miguel Melendez-Ferro, Rosalinda C. Roberts, Basal ganglia pathology in schizophrenia: dopamine connections and anomalies, Journal of Neurochemistry, 2010, 113, 2
  42. You have free access to this content42
    Javier Fernández-Ruiz, Mariluz Hernández, José A. Ramos, Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders, CNS Neuroscience & Therapeutics, 2010, 16, 3
  43. 43
    Susan R Sesack, Anthony A Grace, Cortico-Basal Ganglia Reward Network: Microcircuitry, Neuropsychopharmacology, 2010, 35, 1, 27

    CrossRef

  44. 44
    G. R. Khakimova, E. A. Kozina, A. Ya. Sapronova, M. V. Ugryumov, Dopamine uptake in the substantia nigra and striatum in the presymptomatic and early symptomatic stages in Parkinsonian mice, Doklady Biological Sciences, 2010, 435, 1, 381

    CrossRef

  45. 45
    Marta G. Vučcković, Quanzheng Li, Beth Fisher, Angelo Nacca, Richard M. Leahy, John P. Walsh, Jogesh Mukherjee, Celia Williams, Michael W. Jakowec, Giselle M. Petzinger, Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride, Movement Disorders, 2010, 25, 16
  46. 46
    Mark J. Millan, From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease, Pharmacology & Therapeutics, 2010, 128, 2, 229

    CrossRef

  47. 47
    Chul Hyoung Lyoo, Myung Sik Lee, Levodopa responsive hemidystonia associated with contralateral nigral lesion, Journal of Neurology, 2010, 257, 5, 856

    CrossRef

  48. 48
    H. Lee, H.L. Melrose, M. Yue, Jean-Francois Pare, M.J. Farrer, Y. Smith, Lrrk2 localization in the primate basal ganglia and thalamus: A light and electron microscopic analysis in monkeys, Experimental Neurology, 2010, 224, 2, 438

    CrossRef

  49. 49
    R.P. Clauss, Neurotransmitters in Coma, Vegetative and Minimally Conscious States, pharmacological interventions, Medical Hypotheses, 2010, 75, 3, 287

    CrossRef

  50. 50
    Jongil Lim, Manjit K. Sanghera, Olivier Darbin, R. Malcolm Stewart, Joseph Jankovic, Richard Simpson, Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patients, Experimental Neurology, 2010, 224, 2, 542

    CrossRef

  51. 51
    Alexei Korchounov, Michael F. Meyer, Michael Krasnianski, Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation, Journal of Neural Transmission, 2010, 117, 12, 1359

    CrossRef

  52. 52
    Romulo Fuentes, Per Petersson, Miguel A. L. Nicolelis, Restoration of locomotive function in Parkinson’s disease by spinal cord stimulation: mechanistic approach, European Journal of Neuroscience, 2010, 32, 7
  53. 53
    Y. Smith, J.G. Masilamoni, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  54. 54
    Arthur S. Walters, William G. Ondo, Wen Zhu, Weidong Le, Does the endogenous opiate system play a role in the Restless Legs Syndrome?: A pilot post-mortem study, Journal of the Neurological Sciences, 2009, 279, 1-2, 62

    CrossRef

  55. 55
    Younghee Kim, Minjeong Kim, Hyunji Kim, Kisok Kim, Effect of lavender oil on motor function and dopamine receptor expression in the olfactory bulb of mice, Journal of Ethnopharmacology, 2009, 125, 1, 31

    CrossRef

  56. 56
    R. Bouali-Benazzouz, C.H. Tai, J. Chetrit, A. Benazzouz, Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus, Neuroscience, 2009, 164, 2, 588

    CrossRef

  57. 57
    Irina N. Krasnova, Amber B. Hodges, Bruce Ladenheim, Raina Rhoades, Crystal G. Phillip, Angela Ceseňa, Ekaterina Ivanova, Christine F. Hohmann, Jean Lud Cadet, Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice, Neuroscience Research, 2009, 65, 2, 160

    CrossRef

  58. 58
    Yao-Ying. Ma, Carlos. Cepeda, Cai-Lian. Cui, Novel Approaches to Studying Basal Ganglia and Related Neuropsychiatric Disorders, 2009,

    CrossRef

  59. 59
    Jose A. Obeso, Concepcio Marin, C. Rodriguez-Oroz, Javier Blesa, B. Benitez-Temiño, Juan Mena-Segovia, Manuel Rodríguez, C. Warren Olanow, The basal ganglia in Parkinson's disease: Current concepts and unexplained observations, Annals of Neurology, 2008, 64, S2
  60. 60
    Yoland Smith, Functional Anatomy of the Motor and Non-Motor Circuitry of the Basal Ganglia,